Display options
Cite
López-Riera M, Conde I, Tolosa L, et al. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease. Front Pharmacol. 2017;8:3doi: 10.3389/fphar.2017.00003.
López-Riera, M., Conde, I., Tolosa, L., Zaragoza, �. �., Castell, J. V., Gómez-Lechón, M. J., & Jover, R. (2017). New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease. Frontiers in pharmacology, 83. https://doi.org/10.3389/fphar.2017.00003
López-Riera, Mireia, et al. "New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease." Frontiers in pharmacology vol. 8 (2017): 3. doi: https://doi.org/10.3389/fphar.2017.00003
López-Riera M, Conde I, Tolosa L, Zaragoza Á, Castell JV, Gómez-Lechón MJ, Jover R. New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease. Front Pharmacol. 2017 Jan 25;8:3. doi: 10.3389/fphar.2017.00003. eCollection 2017. PMID: 28179883; PMCID: PMC5263149.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2017 Jan 25;8:3. doi: 10.3389/fphar.2017.00003. eCollection 2017.

New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.

Frontiers in pharmacology

Mireia López-Riera, Isabel Conde, Laia Tolosa, Ángela Zaragoza, José V Castell, María J Gómez-Lechón, Ramiro Jover

Affiliations

  1. Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Hospital Universitari i Politècnic La Fe Valencia, Spain.
  2. Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Hospital Universitari i Politècnic La FeValencia, Spain; Servicio Medicina Digestiva, Sección Hepatología, Hospital Universitari i Politècnic La FeValencia, Spain.
  3. Servicio Medicina Digestiva, Sección Hepatología, Hospital Universitari i Politècnic La Fe Valencia, Spain.
  4. Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Hospital Universitari i Politècnic La FeValencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos IIIMadrid, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universitat de ValènciaValencia, Spain.
  5. Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Hospital Universitari i Politècnic La FeValencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos IIIMadrid, Spain.

PMID: 28179883 PMCID: PMC5263149 DOI: 10.3389/fphar.2017.00003

[No abstract available.]

Keywords: drug-induced steatosis; hepatosteatosis; metabolic syndrome drug; microRNA; non-alcoholic fatty liver disease; predictive biomarker

References

  1. Arch Toxicol. 2006 Sep;80(9):580-604 - PubMed
  2. J Clin Pathol. 2009 Jun;62(6):481-92 - PubMed
  3. Toxicol Pathol. 2005;33(1):146-54 - PubMed
  4. Toxicol In Vitro. 2015 Apr;29(3):489-501 - PubMed
  5. Sci Rep. 2015 Oct 22;5:15501 - PubMed
  6. J Hepatol. 2006 Apr;44(4):732-41 - PubMed
  7. Biotechnol Lett. 2012 Apr;34(4):627-33 - PubMed
  8. Curr Drug Metab. 2012 Oct;13(8):1160-73 - PubMed
  9. Bioinformatics. 2005 May 15;21(10):2548-9 - PubMed
  10. Liver Int. 2006 Jun;26(5):613-20 - PubMed
  11. Nature. 2007 Apr 26;446(7139):975-7 - PubMed
  12. PLoS One. 2013 Jun 07;8(6):e65641 - PubMed
  13. Biotechniques. 2003 Feb;34(2):374-8 - PubMed
  14. Eur Rev Med Pharmacol Sci. 2005 Sep-Oct;9(5):261-3 - PubMed
  15. J Proteome Res. 2014 Mar 7;13(3):1731-43 - PubMed
  16. World J Gastroenterol. 2008 Jan 14;14(2):193-9 - PubMed
  17. J Biol Chem. 2009 Dec 4;284(49):34036-44 - PubMed
  18. Toxicol Mech Methods. 2016 Feb;26(2):112-21 - PubMed
  19. Arch Toxicol. 2015 Oct;89(10 ):1847-60 - PubMed
  20. Mol Diagn Ther. 2013 Dec;17 (6):343-54 - PubMed
  21. Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112 - PubMed
  22. Eur J Gastroenterol Hepatol. 2005 Feb;17(2):141-3 - PubMed
  23. Prog Histochem Cytochem. 2004;39(2):85-128 - PubMed
  24. Sci Rep. 2016 Apr 05;6:23709 - PubMed
  25. Chem Biol Interact. 2007 Jan 30;165(2):106-16 - PubMed
  26. Gene. 2014 Sep 10;548(1):91-100 - PubMed
  27. Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7 - PubMed
  28. Cancer Res. 2004 Aug 1;64(15):5245-50 - PubMed
  29. Arch Toxicol. 2014 Apr;88(4):967-82 - PubMed
  30. J Hepatol. 1997;26 Suppl 2:43-53 - PubMed
  31. PLoS One. 2014 Jun 13;9(6):e99245 - PubMed
  32. Hepatology. 2011 Nov;54(5):1767-76 - PubMed
  33. Semin Liver Dis. 2014 May;34(2):205-14 - PubMed
  34. PLoS One. 2014 Jan 24;9(1):e87179 - PubMed
  35. Science. 2011 Jun 24;332(6037):1519-23 - PubMed

Publication Types